OTC DEAL TRENDS 2015
19 March 2015 - Deborah Wilkes
The 'OTC Deal Trends 2015' Briefing provides a concise analysis of recent acquisitions, mergers and joint ventures in the global consumer healthcare industry.
Analysis of around 60 OTC deals in 2014 revealed 10 key trends:
- Mega OTC deals reshaped the global OTC industry
- Vitamins, minerals and supplements (VMS) attracted a variety of acquirers
- Food companies raced into sports nutrition
- Interesting deals emerged in the skin treatments category
- Emerging markets appealed to acquirers
- Generics companies remained keen to build an OTC presence
- Private-equity firms snapped up OTC assets
- Spin-offs hit the headlines
- OTC assets changed hands as part of wider pharmaceutical deals
- Portfolio streamlining released OTC brands
2014 was a momentous year for the OTC industry. GlaxoSmithKline has created a joint venture with Novartis, Bayer has acquired Merck & Co's Consumer Care business, and Perrigo is purchasing Omega Pharma. It was also a bumper year for all sorts of OTC deals.
This authoritative Briefing from OTCToolbox helps put this deal-making activity in context.
The Briefing is written by OTC industry expert Deborah Wilkes, who is the Editor & Publisher of OTCToolbox.
It is available to purchase and download immediately from the OTCToolbox website as a PDF. Make sure your team is well informed through a Multiple User Licence or a Global Licence for the Briefing. The Briefing is available free to people with an Annual Subscription to the OTCToolbox website.